Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Sues Nucleonics, Ambion, Genscript over RNAi Patent

NEW YORK, March 26 (GenomeWeb News) - Benitec is suing Nucleonics, Ambion, and Genscript in the US for infringing its patent on RNAi technology, the Australian company said yesterday.


Benitec, of Queensland, has filed suits in the US District Court for the District of Delaware, alleging that the three companies are infringing its US Patent No. 6,573,099, entitled "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene." The patent covers DNA-directed RNA interference.


According to Benitec's chairman and CEO, John McKinley, "Benitec will consider additional infringement actions as we deem appropriate in other jurisdictions."

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.